Crystal's Coder Hub🧬 CPT 43270 - Esophagogastroduodenoscopy (EGD), Flexible, Transoral; with Ablation
Quick Reference
wRVU: ~3.60 · Global: 000 · Assistant: ❌ Not Payable · Bilateral: ❌ N/A · Type: Therapeutic — Ablation
📋 Full Code Descriptor
☑️ CPT 43270 - Esophagogastroduodenoscopy, flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) (includes pre- and post-dilation and guide wire passage, when performed)
CPT 43270 describes a therapeutic esophagogastroduodenoscopy (EGD) where the endoscopist uses an ablative technique to destroy a lesion, tumor, polyp, or abnormal tissue within the esophagus, stomach, duodenum, or proximal jejunum.
Common ablation modalities include Radiofrequency Ablation (RFA), Argon Plasma Coagulation (APC), laser coagulation, heater probe, or cryotherapy. This is a definitive treatment code frequently utilized for eradicating dysplastic Barrett’s esophagus or destroying bleeding vascular malformations (like GAVE).
The descriptor explicitly notes that any pre- and post-dilation or guide wire passage performed during the same session to facilitate the scope’s passage or the ablation catheter’s placement is bundled and cannot be reported separately.
🔭 Procedure Overview
What the Endoscopist Does
- Patient is sedated, and the flexible video endoscope is introduced transorally.
- The endoscopist visualizes the esophagus, stomach, and duodenum/proximal jejunum (diagnostic EGD component).
- A targeted lesion or abnormal mucosal area is identified for destruction.
- The Ablation Technique:
- An ablation catheter or probe is passed through the endoscope channel.
- For RFA (e.g., HALO system for Barrett’s): A balloon or focal catheter is deployed and thermal energy is applied to slough off the dysplastic tissue.
- For APC (e.g., for vascular ectasia): Argon gas is ionized by high-frequency current, delivering non-contact thermal coagulation to the bleeding or abnormal vessels.
- The necrotic/ablated tissue may be scraped or washed away.
- The site is inspected to ensure adequate destruction and hemostasis.
Scope Reach Defined
| Structure | Included in 43270 |
|---|---|
| Esophagus | ✅ Always |
| Stomach | ✅ Always |
| Duodenum | ✅ When appropriate |
| Proximal Jejunum | ✅ When appropriate |
💰 Valuation & Reimbursement
| Field | Value |
|---|---|
| wRVU | ~3.60 (Subject to annual MPFS updates) |
| Global Period | 000 days |
| Pre-op Period | 0 days |
| Post-op Period | 0 days |
| Assistant Surgeon Payable | ❌ No |
| Bilateral Procedure | ❌ Not applicable |
| Co-Surgeon (-62) | ❌ Not applicable |
| Multiple Procedure Reduction | ✅ Subject to multiple procedure discount if billed with other non-bundled endoscopy codes |
Moderate Sedation Note
🌲 Code Tree / Code Family
CPT 43270 falls under the therapeutic EGD code family anchored by the diagnostic base code 43235.
43235 ── Diagnostic EGD (base)
│
├── 43239 ── + Biopsy, single or multiple
├── 43248 ── + Dilation of esophagus over guide wire
├── 43249 ── + Esophageal dilation up to 30 mm diameter
├── 43250 ── + Removal of tumor(s)/polyp(s) by hot biopsy forceps
├── 43251 ── + Removal of tumor(s)/polyp(s) by snare technique
├── 43254 ── + Endoscopic mucosal resection (EMR)
├── 43255 ── + Control of bleeding, any method
└── 43270 ── + Ablation of tumor(s), polyp(s), or other lesion(s) ← THIS CODE
✅ Includes (Bundled Into 43270)
The following services are inherent to the ablation procedure and not separately reportable:
- Diagnostic EGD (43235)
- Pre-procedure or post-procedure dilation of the esophagus (43248, 43249)
- Guide wire passage
- Specimen collection by brushing/washing
- Routine control of bleeding induced by the ablation itself
❌ Excludes / Separately Reportable
Do NOT bundle
— report separately when documented on a distinctly separate lesion and medically necessary
| Code | Descriptor | Notes |
|---|---|---|
| 43239 | EGD with biopsy, single or multiple | Separately reportable with modifier -59 or -XS only if the biopsy is taken from a distinct, separate lesion than the ablated area. |
| 43254 | EGD with EMR | Separately reportable if a distinct area is resected via EMR (e.g., EMR of a nodule, followed by RFA of the remaining flat Barrett’s tissue). |
| 43255 | EGD with control of bleeding | Separately reportable only if the bleeding is from a completely distinct source independent of the ablation site. |
🏥 MS-DRG Mapping
Inpatient Context
CPT 43270 is typically an outpatient/ASC procedure (e.g., routine Barrett’s surveillance and treatment). If performed inpatient, MS-DRG assignment is driven by the principal diagnosis (e.g., acute hemorrhage from AVMs or esophageal dysplasia).
Common Inpatient DRG Contexts for 43270
| MS-DRG | Title | Common Principal Dx |
|---|---|---|
| 368 | Major Esophageal Disorders with MCC | C15.9, K22.711 (if MCC present) |
| 369 | Major Esophageal Disorders with CC | K22.711 |
| 370 | Major Esophageal Disorders without CC/MCC | K22.710, K22.711 |
| 377 | GI Hemorrhage with MCC | K31.811 (if MCC present) |
| 378 | GI Hemorrhage with CC | K31.811 |
| 379 | GI Hemorrhage without CC/MCC | K31.811 |
🔬 Commonly Associated ICD-10-CM Diagnoses
Dysplasia and Neoplasms
| ICD-10-CM | Descriptor | HCC | Notes |
|---|---|---|---|
| K22.710 | Barrett’s esophagus with low-grade dysplasia | Non-HCC | Common indication for RFA. |
| K22.711 | Barrett’s esophagus with high-grade dysplasia | Non-HCC | Primary indication for definitive RFA therapy. |
| C15.9 | Malignant neoplasm of esophagus, unspecified | HCC 10 (v24) / HCC 17 (v28) | Palliative ablation or early-stage destruction. |
| D13.0 | Benign neoplasm of esophagus | Non-HCC | — |
| D13.1 | Benign neoplasm of stomach | Non-HCC | — |
Vascular Lesions and Bleeding
| ICD-10-CM | Descriptor | HCC | Notes |
|---|---|---|---|
| K31.811 | Angiodysplasia of stomach and duodenum with bleeding | Non-HCC | Gastric Antral Vascular Ectasia (GAVE) treated with APC. |
| K31.819 | Angiodysplasia of stomach and duodenum without bleeding | Non-HCC | Prophylactic ablation. |
| K22.82 | Esophageal polyp | Non-HCC | — |
| I78.0 | Hereditary hemorrhagic telangiectasia | Non-HCC | Osler-Weber-Rendu syndrome causing upper GI bleeding. |
🔧 Applicable Modifiers
| Modifier | Name | When to Use with 43270 |
|---|---|---|
| -52 | Reduced Services | The ablation was planned and scope introduced, but the procedure was terminated before the ablation could be completed (e.g., equipment failure, poor visualization). |
| -59 | Distinct Procedural Service | Used when billing another therapeutic EGD code (like biopsy 43239 or EMR 43254) on a distinct, separate lesion/site during the same session. |
| -XS | Separate Structure | Highly recommended over -59 for Medicare when a separate lesion/organ structure is treated (e.g., Ablation in esophagus, biopsy in stomach). |
| -51 | Multiple Procedures | Used if another distinct procedure (e.g., Colonoscopy) is performed during the same encounter. |
📖 Documentation Requirements
For compliant reporting of 43270, the operative report must explicitly document:
- Identification of the Lesion — The specific location, size, and type of abnormal tissue targeted.
- Ablation Modality — Explicit mention of the technology used (e.g., “Barrx Radiofrequency Ablation system,” “Argon Plasma Coagulation,” “Nd:YAG laser”).
- Execution of Ablation — Documentation that thermal/cryo energy was actively delivered to destroy the tissue.
- Separate Lesions (if applicable) — If biopsies or EMR were performed, the report must clearly identify them as being in a distinct anatomical location or a completely separate lesion from the ablated site.
🧪 Coding Examples
Example 1 — RFA for Barrett’s Esophagus
A 61-year-old male with a history of Barrett’s esophagus with high-grade dysplasia presents for scheduled ablation. The endoscope is inserted, and a 3 cm segment of Barrett’s mucosa is identified in the distal esophagus. The Barrx 360 RFA balloon catheter is introduced over a guidewire. Circumferential radiofrequency ablation is delivered to the segment. The ablated coagulum is scraped away, and a second pass of ablation is performed.
CPT: 43270 (Guidewire passage is bundled into the ablation) ICD-10-CM: K22.711 — Barrett’s esophagus with high-grade dysplasia
Example 2 — APC for Bleeding Gastric AVMs
An inpatient EGD is performed for a patient presenting with melena and a drop in hemoglobin. The scope is advanced into the stomach. The endoscopist visualizes classic “watermelon stomach” (Gastric Antral Vascular Ectasia) with active oozing. An Argon Plasma Coagulation (APC) probe is passed through the scope, and thermal ablation is applied to the vascular lesions until the bleeding ceases and the lesions are destroyed.
CPT: 43270 ICD-10-CM: K31.811 — Angiodysplasia of stomach and duodenum with bleeding (Note: 43270 is reported instead of 43255 for hemostasis because the APC technique specifically destroyed the vascular lesions/AVMs).
Example 3 — EMR of Nodule followed by RFA of Flat Mucosa
A patient with Barrett’s esophagus has a distinct 1 cm nodule in the mid-esophagus and flat dysplastic tissue in the distal esophagus. The endoscopist performs an Endoscopic Mucosal Resection (EMR) with submucosal lifting and snare on the mid-esophageal nodule. Subsequently, the focal RFA paddle is used to ablate the separate flat dysplastic mucosa in the distal esophagus.
CPT Codes:
ICD-10-CM: K22.711 — Barrett’s esophagus with high-grade dysplasia (Note: Modifier -XS/-59 is supported because the EMR and the ablation were performed on distinctly separate mucosal areas).
⚠️ Coding Pitfalls & Compliance Notes
Common Errors
- Coding dilation separately: CPT rules explicitly state that pre- and post-dilation are included in 43270. Never bill 43248 or 43249 alongside 43270 during the same session, even if modifiers are applied, unless the dilation is on a completely separate stricture unrelated to the ablation.
- Billing biopsy on the same lesion: If the endoscopist biopsies a dysplastic area, realizes it is abnormal, and immediately ablates that exact same area, only the ablation (43270) is reported. You cannot bill 43239 and 43270 for the same target tissue.
- Confusing bleeding control (43255) with ablation (43270): If APC or a heater probe is used purely to stop an actively bleeding ulcer, report 43255. However, if the tool is used to destroy a structural lesion (like an AVM, tumor, or polyp) that happens to be bleeding, 43270 is the more accurate code because the primary intent is lesion destruction.
🔗 Related Notes
- 43235 — EGD, diagnostic (base code)
- 43239 — EGD with biopsy, single or multiple
- 43248 — EGD with dilation of esophagus over guide wire
- 43249 — EGD with esophageal dilation up to 30 mm diameter
- 43254 — EGD with endoscopic mucosal resection (EMR)
- 43255 — EGD with control of bleeding
- 45388 — Colonoscopy with ablation (lower GI counterpart)
- K22.710 — Barrett’s esophagus with low-grade dysplasia
- K22.711 — Barrett’s esophagus with high-grade dysplasia
- K31.811 — Angiodysplasia of stomach and duodenum with bleeding
AMA CPT Codebook 2025 · CMS Physician Fee Schedule · CMS National Correct Coding Initiative (NCCI) Policy Manual · ICD-10-CM Official Guidelines for Coding and Reporting · AAPC Gastroenterology Coding Reference